Liju Zong

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Endometrial Cancer

Prognostic Factors

Top Venues

Journal of clinical medicine

Cancer immunology, immunotherapy : CII

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Liju Zong, Shengwei Mo, Zezheng Sun, Zhaohui Lu, Jie Chen, Shuangni Yu, Yang Xiang
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas. Journal of clinical medicine 12 (2) (2023)
Liju Zong, Shengwei Mo, Zezheng Sun, Zhaohui Lu, Jie Chen, Shuangni Yu, Yang Xiang
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas. Journal of clinical medicine 12 (2) (2023)
Liju Zong, Shengwei Mo, Zezheng Sun, Zhaohui Lu, Jie Chen, Shuangni Yu, Yang Xiang
Incorporating Molecular Classification When Stratifying the Survival Risk of Patients with High-Grade Endometrial Carcinomas. Journal of clinical medicine 12 (2) (2023)
Shuangni Yu, Zezheng Sun, Liju Zong, Jie Yan, Mei Yu, Jie Chen, Zhaohui Lu
Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study. Journal of gynecologic oncology 33 (3) (2022)
Qianqian Zhang, Liju Zong, Hui Zhang, Wei Xie, Fan Yang, Wenwen Sun, Baoxia Cui, Youzhong Zhang
B7-H4 Expression in Precancerous Lesions of the Uterine Cervix. BioMed research international 2021 (2021)
Liju Zong, Yu Gu, Yuncan Zhou, Yujia Kong, Shengwei Mo, Shuangni Yu, Yang Xiang, Jie Chen
Expression of B7 family checkpoint proteins in cervical cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2021)
Liju Zong, Shengwei Mo, Zezheng Sun, Zhaohui Lu, Shuangni Yu, Jie Chen, Yang Xiang
Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2021)
Liju Zong, Shengwei Mo, Shuangni Yu, Yuncan Zhou, Ming Zhang, Jie Chen, Yang Xiang
Expression of the immune checkpoint VISTA in breast cancer. Cancer immunology, immunotherapy : CII 69 (8) (2020)
Liju Zong, Yuncan Zhou, Ming Zhang, Jie Chen, Yang Xiang
VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer. Cancer immunology, immunotherapy : CII 69 (1) (2019)